首页 › 基金 › DCF Advisers, LLC › LFCR
DCF Advisers, LLC 对 LFCR 的持仓历史
LIFECORE BIOMEDICAL INC · 医疗保健
DCF Advisers, LLC 在 Q3 2026 的 13F 申报中披露持有 LFCR(LIFECORE BIOMEDICAL INC)376,500 股,市值约 US$2.5M,约占其申报组合的 0.73%,在其申报持仓中市值排名第 34 位。 DCF Advisers, LLC 最近 13 个申报季度中有 13 个季度披露了 LFCR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
DCF Advisers, LLC 对 LFCR 的持仓演变
DCF Advisers, LLC 于 Q3 2023 首次披露 LFCR 持仓:120,754 股(约 US$911K)。 该持仓在 Q4 2024 达到峰值 539,989 股,市值约 US$4.0M。 在 13 次申报中,DCF Advisers, LLC 4 次增持、7 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 376,500 股、市值约 US$2.5M,环比减持 -48,000 股。。 持仓曾出现大幅变动:Q4 2023 增持约 115% (随后一个季度股价下跌 14%)、Q4 2024 增持约 87% (随后一个季度股价下跌 5%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 120.75K | $911.09K | 新进 |
| Q4 2023 | 259.68K | $1.61M | 增持 |
| Q1 2024 | 284.68K | $1.51M | 增持 |
| Q2 2024 | 290.68K | $1.49M | 增持 |
| Q3 2024 | 288.48K | $1.42M | 减持 |
| Q4 2024 | 539.99K | $4.01M | 增持 |
| Q1 2025 | 483.00K | $3.40M | 减持 |
| Q2 2025 | 462.99K | $3.76M | 减持 |
| Q3 2025 | 452.00K | $3.33M | 减持 |
| Q4 2025 | 442.00K | $3.62M | 减持 |
| Q1 2026 | 424.50K | $1.58M | 减持 |
| Q2 2026 | 424.50K | $2.23M | 持有 |
| Q3 2026 | 376.50K | $2.48M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LFCR 与 13F 数据
LFCR(LIFECORE BIOMEDICAL INC)属于医疗保健行业。我们追踪的基金中还有 21 只申报持有 LFCR,申报仓位最大的包括:WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$16.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LFCR 的基金
- WYNNEFIELD CAPITAL INC 4.70M 股 · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M 股 · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 3.19M 股 · $16.75M · Q2 2026
- 325 CAPITAL LLC 2.90M 股 · $15.20M · Q2 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 314.01K 股 · $1.65M · Q2 2026
更多关于 DCF Advisers, LLC
常见问题
How long has DCF Advisers, LLC held LFCR?
DCF Advisers, LLC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DCF Advisers, LLC's current position in LFCR?
As of Q3 2026, DCF Advisers, LLC holds 376.50K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $2.48M, representing 0.73% of its reported portfolio and ranking #34.
Has DCF Advisers, LLC been buying or selling LFCR?
In the latest 13F filing (Q3 2026), DCF Advisers, LLC reduced its position in LFCR. The position peaked in Q4 2024 at 539.99K shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.